A genetic mouse model mimicking MET related human osteofibrous dysplasia is characterized by delays in fracture repair and defective osteogenesis.
Guo-Ju HongWilliam XieKashif AhmedConnor ObornCarrie-Lynn SoltysPeter KannuPublished in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology (2024)
Osteofibrous dysplasia (OFD) is a rare, benign, fibro-osseous lesion that occurs most commonly in the tibia of children. Tibial involvement leads to bowing and predisposes to the development of a fracture which exhibit significantly delayed healing processes, leading to prolonged morbidity. We previously identified gain-of-function mutations in the MET gene as a cause for OFD. In our present study, we test the hypothesis that gain-of-function MET mutations impair bone repair due to reduced osteoblast differentiation. A heterozygous Met exon 15 skipping (Met Δ15 -HET) mouse was created to imitate the human OFD mutation. The mutation results in aberrant and dysregulation of MET-related signaling determined by RNA-seq in the murine osteoblasts extracted from the wide-type and genetic mice. Although no gross skeletal defects were identified in the mice, fracture repair was delayed in Met Δ15 -HET mice, with decreased bone formation observed 2-week postfracture. Our data are consistent with a novel role for MET-mediated signaling regulating osteogenesis.
Keyphrases
- tyrosine kinase
- rna seq
- endothelial cells
- single cell
- high fat diet induced
- genome wide
- type diabetes
- copy number
- young adults
- randomized controlled trial
- clinical trial
- early onset
- bone regeneration
- body composition
- machine learning
- gene expression
- metabolic syndrome
- induced pluripotent stem cells
- bone mineral density
- electronic health record
- postmenopausal women
- hip fracture
- double blind
- genome wide identification